These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 9765760

  • 1. Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
    Figueredo A, Germond C, Maroun J, Browman G, Walker-Dilks C, Wong S.
    Cancer Prev Control; 1997 Dec; 1(5):379-92. PubMed ID: 9765760
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
    Figueredo A, Fine S, Maroun J, Walker-Dilks C, Wong S.
    Cancer Prev Control; 1997 Oct; 1(4):304-19. PubMed ID: 9765754
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM, Lochrin CA, Darling G, Eady A, Newman TE, Evans WK.
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [Abstract] [Full Text] [Related]

  • 4. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G, Rusthoven J, Newman T, Findlay B, Evans W.
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [Abstract] [Full Text] [Related]

  • 5. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
    Whelan TJ, Lada BM, Laukkanen E, Perera FE, Shelley WE, Levine MN.
    Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
    [Abstract] [Full Text] [Related]

  • 6. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
    Brundage MD, Crook JM, Lukka H.
    Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
    [Abstract] [Full Text] [Related]

  • 7. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
    Rusthoven J, Bramwell V, Stephenson B.
    Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
    [Abstract] [Full Text] [Related]

  • 8. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
    Benson AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG.
    J Clin Oncol; 2004 Aug 15; 22(16):3408-19. PubMed ID: 15199089
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy in stage IV (metastatic) non-small-cell lung cancer. Provincial Lung Disease Site Group.
    Lopez PG, Stewart DJ, Newman TE, Evans WK.
    Cancer Prev Control; 1997 Aug 15; 1(1):18-27. PubMed ID: 9765723
    [Abstract] [Full Text] [Related]

  • 10. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM.
    J Clin Oncol; 2004 May 15; 22(10):1797-806. PubMed ID: 15067028
    [Abstract] [Full Text] [Related]

  • 11. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ, Feigl P, Quan G, Fenoglio-Preiser C, Lovato LC, Bunn PA, Stemmerman G, Wells JD, Macdonald JS, Meyskens FL.
    Cancer Res; 1998 Mar 15; 58(6):1149-58. PubMed ID: 9515799
    [Abstract] [Full Text] [Related]

  • 12. Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group.
    Goss GD, Logan DM, Newman TE, Evans WK.
    Cancer Prev Control; 1997 Mar 15; 1(1):28-38. PubMed ID: 9765724
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.
    Jonker DJ, Spithoff K, Maroun J, Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care.
    Clin Oncol (R Coll Radiol); 2011 Jun 15; 23(5):314-22. PubMed ID: 21397476
    [Abstract] [Full Text] [Related]

  • 14. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Goss G, Paszat L, Newman TE, Evans WK, Browman G.
    Cancer Prev Control; 1998 Feb 15; 2(1):32-9. PubMed ID: 9765764
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O, Fluge Ø, Carlsen E, Wiig JN, Myrvold HE, Vonen B, Podhorny N, Bjerkeset O, Eide TJ, Halvorsen TB, Tveit KM, Norwegian Gastrointestinal Cancer Group.
    Acta Oncol; 2009 Feb 15; 48(3):368-76. PubMed ID: 19242829
    [Abstract] [Full Text] [Related]

  • 17. Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.
    Skillings JR, Levine M, Rayner HL, Eisenhauer E, Erlichman C, Germond C, Kerr I, Lofters W, Maroun J, Yoshida S.
    CMAJ; 1991 Feb 01; 144(3):297-301. PubMed ID: 1989708
    [Abstract] [Full Text] [Related]

  • 18. New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.
    Benson AB.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 2):6913s-20s. PubMed ID: 18006800
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.